602312-70-9

Upstream product

• 104-10-9 2-(4'-aminophenyl)ethyl alcohol 
• 956697-15-7 acetic acid 2-{4-[6-amino-5-(4-fluoro-benzoyl)-2-oxo-2H-pyridin-1-yl]-phenyl}-ethyl ester 
• 956697-16-8 acetic acid 2-(4-{[3-(4-fluoro-phenyl)-3-oxo-propionimidoyl]-amino}-phenyl)-ethyl ester 
• 721882-81-1 3-(4-fluoro-phenyl)-3-oxo-thiopropionimidic acid 4-chloro-phenyl ester 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 956697-14-6 1-benzyl 2-cyclopentyl 4-[2-(4-{6-amino-5-[(4-fluorophenyl)carbonyl]-2-oxopyridin-1(2H)-yl}phenyl)ethyl]piperazine-1,2-dicarboxylate 

Relevant academic research and scientific papers

INHIBITORS OF P38 MAP KINASE

Compounds of formula (I) are inhibitors of p38 MAP kinase, and are therefore of utility in the treatment of, inter alia, inflammatory conditions including rheumatoid arthritis and COPD: wherein: G is -N= or -CH=; B is an optionally substituted divalent mo

p38 MAP KINASE INHIBITORS

Compounds of formula (I) are inhibitors of p38 MAP kinase, and are therefore of utility in the treatment of, inter alia, inflammatory conditions including rheumatoid arthritis and COPD: (I), wherein: G is -N= or -CH=; D is an optionally substituted divale

MONOCYCLIC AROYLPYRIDINONES AS ANTIINFLAMMATORY AGENTS

The present invention relates to monocyclic aroylpyridinones, processes for their preparation, and their use in medicaments, especially for the treatment of COPD: (formula I).